A Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP of the European Pharmacopoeia monograph is often referred to as a Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) Certificate of Suitability (COS). The purpose of a Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) to their clients by showing that a Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP has been issued for it. The manufacturer submits a Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP holder for the record. Additionally, the data presented in the Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) DMF.
A Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate) suppliers with CEP (COS) on PharmaCompass.